Lumentum (NASDAQ: LITE) has recently received a number of price target changes and ratings updates: 8/21/2026 – Lumentum had its “outperform” rating reaffirmed by Wolfe Research. 8/20/2026 – Lumentum was upgraded by Zacks Research from “hold” to “strong-buy”. 8/19/2026 – Lumentum was downgraded by Weiss Ratings from “hold (c-)” to “sell (d-)”. 8/12/2026 – Lumentum […]

Kura Oncology (NASDAQ: KURA) has recently received a number of price target changes and ratings updates: 8/24/2026 – Kura Oncology was given a new $24.00 price target by Raymond James Financial, Inc.. 8/24/2026 – Kura Oncology was given a new $24.00 price target by Morgan Stanley. 8/24/2026 – Kura Oncology had its “market outperform” rating […]

Jack In The Box (NASDAQ: JACK) recently received a number of ratings updates from brokerages and research firms: 8/13/2026 – Jack In The Box had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $16.00 price target on the stock. 8/13/2026 – Jack In The Box had its price target raised by […]

Several brokerages have updated their recommendations and price targets on shares of ATI (NYSE: ATI) in the last few weeks: 8/12/2026 – ATI had its price target raised by KeyCorp from $211.00 to $258.00. They now have an “overweight” rating on the stock. 8/10/2026 – ATI had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. […]

Zimmer Biomet (NYSE: ZBH) recently received a number of ratings updates from brokerages and research firms: 8/10/2026 – Zimmer Biomet had its price target raised by Canaccord Genuity Group Inc. from $83.00 to $100.00. They now have a “hold” rating on the stock. 8/8/2026 – Zimmer Biomet was downgraded by Wall Street Zen from “buy” […]

Tenax Therapeutics (NASDAQ: TENX) recently received a number of ratings updates from brokerages and research firms: 8/15/2026 – Tenax Therapeutics was downgraded by Wall Street Zen from “sell” to “strong sell”. 8/11/2026 – Tenax Therapeutics was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 8/11/2026 – Tenax Therapeutics was given a new $4.00 […]

Several analysts have recently updated their ratings and price targets for MYR Group (NASDAQ: MYRG): 8/16/2026 – MYR Group was upgraded by Wall Street Zen from “buy” to “strong-buy”. 8/13/2026 – MYR Group had its price target lowered by The Goldman Sachs Group, Inc. from $469.00 to $422.00. They now have a “neutral” rating on […]

Choice Hotels International (NYSE: CHH) has recently received a number of price target changes and ratings updates: 8/18/2026 – Choice Hotels International had its price target raised by Morgan Stanley from $86.00 to $91.00. They now have an “underweight” rating on the stock. 8/11/2026 – Choice Hotels International had its price target raised by Susquehanna […]

Several analysts have recently updated their ratings and price targets for Easterly Government Properties (NYSE: DEA): 8/24/2026 – Easterly Government Properties had its “hold (c-)” rating reaffirmed by Weiss Ratings. 8/24/2026 – Easterly Government Properties had its “underperform” rating reaffirmed by Royal Bank Of Canada. They now have a $24.00 price target on the stock, […]

Vivmark Residential Common Shares of Beneficial Interest (NYSE: VMRK) recently received a number of ratings updates from brokerages and research firms: 8/26/2026 – Vivmark Residential Common Shares of Beneficial Interest had its price target raised by Piper Sandler from $75.00 to $76.00. They now have a “neutral” rating on the stock. 8/26/2026 – Vivmark Residential […]